Vancouver, B.C., November 17, 2026 – TheNewswire – Canam Biotech Inc. (the “Company”) is pleased to announce that it set the effective date as November 16, 2026 (the “Effective Date”) for the spinout of 1207331 B.C. Ltd. (“331BC”), a wholly owned subsidiary of the Company formed to conduct a transaction under its 2019 plan of arrangement (the “Arrangement”).
Under the Arrangement, the effective date for the Arrangement can be set separately as between the Company and each of the other parties to the Arrangement. The share distribution record date for the Arrangement as between the Company and 331BC was set to the end of business day on November 4, 2026 (as previously announced through a press release by the Company), which is the record date of the shareholders of the Company who would be entitled to receive shares of 331BC on the effectiveness of the Arrangement as between the Company and 331BC. The Company’s shareholders of record as of November 4, 2026 eligible to receive shares of 331BC under the Arrangement received a total of 551,634 common shares of 331BC, subject to rounding down for any fractional shares, with a fair value of $0.001813 per share and $1,000 aggregate value issued effective November 16, 2026.
About the Company
Canam Biotech Inc. is an early-stage biotech company looking to acquire or develop commercial products and/or technology in Canada.
For further information please contact:
J. Scott Munro, CEO
E-mail: admin@munrofinancial.ca
Cautionary Note Regarding Forward Looking Information
This press release contains projections and forward-looking information that involve various risks and uncertainties regarding future events. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company assumes no obligation to update forward-looking information should circumstances or management’s estimates or opinions change.
Copyright (c) 2026 TheNewswire – All rights reserved.


